The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Dry powder inhalers for pulmonary drug delivery
Abstract
The pulmonary route is an interesting route for drug administration, both for effective local therapy (asthma, chronic obstructive pulmonary disease or cystic fibrosis) and for the systemic administration of drugs (e.g., peptides and proteins). Well-designed dry powder inhalers are highly efficient systems for pulmonary drug delivery. However, they are also complicated systems, the the performance of which relies on many aspects, including the design of the inhaler (e.g., resistance to air flow and the used de-agglomeration principle to generate the inhalation aerosol), the powder formulation and the air flow generated by the patient. The technical background of these aspects, and how they may be tuned in order to obtain desired performance profiles, is reviewed. In light of the technical background, new developments and possibilities for further improvements are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prigogine, I., Stengers, I., & Pagels, H. R. (1984) · Cited by 2,468
Aerosol Technology : Properties, Behavior, and Measurement of Airborne Particles
Hinds, W. C. (1982) · Cited by 1,470
Large Porous Particles for Pulmonary Drug Delivery
Edwards, D. A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M. L., Mintzes, J., Deaver, D., Lotan, N., & Langer, R. (1997) · Science · doi:10.1126/science.276.5320.1868 · Cited by 1,174
Mechanisms of macromolecule absorption by the lungs
Patton, J. S. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00113-l · Cited by 641
Management of Pulmonary Disease in Patients with Cystic Fibrosis
Ramsey, B. W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607183350307 · Cited by 502
The Ciba Collection of Medical Illustrations
(1955) · Journal of the American Medical Association · doi:10.1001/jama.1955.02960040113036 · Cited by 471
Leach, C., Davidson, P., & Boudreau, R. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12061346 · Cited by 430
Brocklebank, D., Ram, F., Wright, J., Barry, P., Cates, C., Davies, L., Douglas, G., Muers, M., Smith, D., & White, J. (2001) · Health Technology Assessment · doi:10.3310/hta5260 · Cited by 401
Pandey, R. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg477 · Cited by 388
Protein Inhalation Powders: Spray Drying vs Spray Freeze Drying
Maa, Y.-F., Nguyen, P.-A., Sweeney, T., Shire, S. J., & Hsu, C. C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018828425184 · Cited by 356
A comparison of the efficacy and safety of inhaled corticosteroids in asthma
Pedersen, S., & O'Byrne, P. (1997) · Allergy · doi:10.1111/j.1398-9995.1997.tb05047.x · Cited by 352
Recent advances in pulmonary drug delivery using large, porous inhaled particles
Edwards, D. A., Ben-Jebria, A., & Langer, R. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.2.379 · Cited by 341
CLARK, A. R., & HOLLINGWORTH, A. M. (1993) · Journal of Aerosol Medicine · doi:10.1089/jam.1993.6.99 · Cited by 332
Formulation and Physical Characterization of Large Porous Particles for Inhalation
Vanbever, R., Mintzes, J. D., Wang, J., Nice, J., Chen, D., Batycky, R., Langer, R., & Edwards, D. A. (1999) · Pharmaceutical Research · doi:10.1023/a:1018910200420 · Cited by 314
Quantitative Structural Analysis of Peripheral Airways and Arteries in Sudden Fatal Asthma
Saetta, M. P., Stefano, A. D., Rosina, C., Thiene, G., & Fabbri, L. M. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/143.1.138 · Cited by 310
Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study
Skyler, J. S., Cefalu, W. T., Kourides, I. A., Landschulz, W. H., Balagtas, C. C., Cheng, S.-L., & Gelfand, R. A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03638-2 · Cited by 301
Autoradiographic visualization of beta-adrenoceptor subtypes in human lung.
Carstairs, J. R., Nimmo, A. J., & Barnes, P. J. (1985) · PubMed · doi:10.1164/arrd.1985.132.3.541 · Cited by 278
The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics
Carroll, N., Cooke, C., & James, A. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10020292 · Cited by 273
Fundamentals of pulmonary drug delivery
GRONEBERG, D. A., WITT, C., WAGNER, U., CHUNG, K. F., & FISCHER, A. (2003) · Respiratory Medicine · doi:10.1053/rmed.2002.1457 · Cited by 270
Strategies for particle design using supercritical fluid technologies
York, P. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00209-6 · Cited by 232
The Local Side Effects of Inhaled Corticosteroids
Roland, N. J., Bhalla, R. K., & Earis, J. (2004) · Chest · doi:10.1378/chest.126.1.213 · Cited by 216
Dry Powder Aerosols I: A New Powder Inhalation Device
Bell, J. H., Hartley, P. S., & Cox, J. S. G. (1971) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600601028 · Cited by 202
Biopharmaceutical Powders Particle Formation and Formulation Considerations
Maa, Y.-F., & Prestrelski, S. (2000) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201003378898 · Cited by 200
Inhaled Human Insulin Treatment in Patients with Type 2 Diabetes Mellitus
Cefalu, W. T., Skyler, J. S., Kourides, I. A., Landschulz, W. H., Balagtas, C. C., Cheng, S.-L., Gelfand, R. A., & for the Inhaled Insulin Study Group* (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-3-200102060-00011 · Cited by 199
Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers
Pauwels, R., Newman, S., & Borgstrom, L. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10092127 · Cited by 198
Patton, J. S., Bukar, J., & Nagarajan, S. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00074-x · Cited by 193
Inulin glasses for the stabilization of therapeutic proteins
Hinrichs, W. L. J., Prinsen, M., & Frijlink, H. W. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00677-3 · Cited by 187
Self-citationKawashima, Y., Yamamoto, H., Takeuchi, H., Fujioka, S., & Hino, T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00048-6 · Cited by 178
Detecting early structural lung damage in cystic fibrosis
Tiddens, H. A. W. M. (2002) · Pediatric Pulmonology · doi:10.1002/ppul.10134 · Cited by 177
Alternative sugars as potential carriers for dry powder inhalations
Steckel, H., & Bolzen, N. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.10.039 · Cited by 176
Identification and containment of an outbreak of SARS in a community hospital.
Dwosh, H. A., Hong, H. H. L., Austgarden, D., Herman, S., & Schabas, R. (2003) · Europe PMC (PubMed Central) · Cited by 172
Prime, D. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00510-3 · Cited by 170
Delivery of Biotherapeutics by Inhalation Aerosol
Niven, R. W. (1995) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v12.i2-3.20 · Cited by 163
Kawashima, Yoshiaki, Yamamoto, Y., Hiromitsu, Takéuchi, Hirofumi, Fujioka, Satoshi, S., Hino, & Tomoaki (2000) · 岐阜藥科大學紀要 = The annual proceedings of Gifu College of Pharmacy · Cited by 155
Mathematical Model for the Selective Deposition of Inhaled Pharmaceuticals
Martonen, T. B. (1993) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600821202 · Cited by 151
Improved Lung Delivery from a Passive Dry Powder Inhaler Using an Engineered PulmoSphere® Powder
Duddu, S. P., Sisk, S. A., Walter, Y. H., Tarara, T. E., Trimble, K. R., Clark, A. R., Eldon, M. A., Elton, R. C., Pickford, M., Hirst, P. H., et al. (2002) · Pharmaceutical Research · doi:10.1023/a:1015322616613 · Cited by 150
Inhalation of antibiotics in cystic fibrosis
Touw, D. J., Brimicombe, R., Hodson, M. E., Heijerman, H. G. M., & Bakker, W. M. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08091594 · Cited by 139
Cellular Infiltration of the Airways in Asthma of Varying Severity
Synek, M., Beasley, R. W., Frew, A. J., Goulding, D., Holloway, L., Lampe, F. C., Roche, W. R., & Holgate, S. T. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.1.8680684 · Cited by 134
Localization of β-adrenoreceptors in mammalian lung by light microscopic autoradiography
Barnes, P. J., Basbaum, C. B., Nadel, J. A., et al. (1982) · Nature · doi:10.1038/299444a0 · Cited by 131
Latest advances in the development of dry powder inhalers
Ashurst, I., Malton, A., Prime, D., & SUMBY, B. S. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00275-3 · Cited by 128
Alveolar macrophages are a primary barrier to pulmonary absorption of macromolecules
Lombry, C., Edwards, D. A., Véronique Préat, A., & Rita Vanbever, A. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00260.2003 · Cited by 126
Physical Stability of Salmon Calcitonin Spray-Dried Powders for Inhalation
Chan, H., Clark, A. R., Feeley, J. C., Kuo, M.-C., Lehrman, S., Pikal‐Cleland, K. A., Miller, D. P., Vehring, R., & Lechuga‐Ballesteros, D. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10594 · Cited by 99
Pulmonary Drug Delivery: Physiologic and Mechanistic Aspects
Yu, J., & Chien, Y. W. (1997) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v14.i4.20 · Cited by 98
The optimal particle size for β-adrenergic aerosols in mild asthmatics
Zanen, P., Go, L. T., & Lammers, J. J. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90436-7 · Cited by 85
Irngartinger, M., Camuglia, V., Damm, M., Goede, J., & Frijlink, H. W. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.016 · Cited by 80
Self-citationOlsson, B. (1995) · Journal of Aerosol Medicine · doi:10.1089/jam.1995.8.suppl_3.s-13 · Cited by 73
Brown, J. S., Zeman, K. L., & Bennett, W. D. (2001) · Journal of Aerosol Medicine · doi:10.1089/08942680152744659 · Cited by 71
de Boer, A. H., Winter, H. M. I., & Lerk, C. F. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04326-8 · Cited by 65
Is total particle dose more important than particle distribution?
Chrystyn, H. (1997) · Respiratory Medicine · doi:10.1016/s0954-6111(97)90100-1 · Cited by 48
Lung deposition of salbutamol in healthy human subjects from the MAGhaler dry powder inhaler
Newman, S. P., MALIK, S., Hirst, P. H., Pitcairn, G. R., van der Heide, A., Pabst, J., DINKELAKER, A., & Fleischer, W. (2002) · Respiratory Medicine · doi:10.1053/rmed.2002.1387 · Cited by 38
Low molecular weight PLA: a suitable polymer for pulmonary administered microparticles?
Wichert, B., & Rohdewald, P. J. (1993) · Journal of Microencapsulation · doi:10.3109/02652049309104385 · Cited by 25
The effect of learning on ventilatory responses to inspiratory threshold loading in COPD
Sturdy, G., Hillman, D. R., GREEN, D. J., JENKINS, S. C., Cecins, N. M., & Eastwood, P. R. (2003) · Respiratory Medicine · doi:10.1016/j.rmed.2003.07.005 · Cited by 22
Can Tobramycin Inhalation Be Improved With a Jet Nebulizer?
Brun, P. P. H. L., Vinks, A. A. T. M. M., Touw, D. J., Hekelaar, N., Mannes, G. P. M., Brimicombe, R. W., Frijlink, H. W., & Heijerman, H. G. M. (1999) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199912000-00007 · Cited by 22
Self-citationDelivery of Therapeutic Peptides and Proteins
Mackay, M. W. (1990) · Developments in biotherapie · doi:10.1007/978-94-011-3780-5_42 · Cited by 4
Cited by
The History of Therapeutic Aerosols: A Chronological Review
Stein, S. W., & Thiel, C. G. (2017) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2016.1297 · Cited by 309
Technological and practical challenges of dry powder inhalers and formulations
Hoppentocht, M., Hagedoorn, P., Frijlink, H. W., & de Boer, A. H. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.04.004 · Cited by 303
Self-citationDry powder inhalation: past, present and future
de Boer, A. H., Hagedoorn, P., Hoppentocht, M., Buttini, F., Grasmeijer, F., & Frijlink, H. W. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1224846 · Cited by 271
Self-citationPulmonary drug delivery systems for tuberculosis treatment
Pham, D.-D., Fattal, E., & Tsapis, N. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.009 · Cited by 185
Metadata
- Authors
- Frijlink, H. W., & De Boer, A. H.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2004-11
- Volume
- 1
- Issue
- 1
- Pages
- 67-86
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2112679976
- Cited by
- 259
- References
- 54
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.